IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival

Despite high remission rates after chemotherapy, only 30–40% of acute myeloid leukemia (AML) patients survive 5 years after diagnosis. This extremely poor prognosis of AML is mainly caused by treatment failure due to chemotherapy resistance. Chemotherapy resistance can be caused by various features...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhagen, H JMP, de Leeuw, D C, Roemer, M GM, Denkers, F, Pouwels, W, Rutten, A, Celie, P H, Ossenkoppele, G J, Schuurhuis, G J, Smit, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611740/
https://www.ncbi.nlm.nih.gov/pubmed/24967962
http://dx.doi.org/10.1038/cddis.2014.268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611740/
https://www.ncbi.nlm.nih.gov/pubmed/24967962
http://dx.doi.org/10.1038/cddis.2014.268

Ejemplares similares